This is a preprint.
Renalase Levels are Decreased in Maternal Blood and Placental Tissues in Pregnancies Associated with Preterm Preeclampsia
- PMID: 38765989
- PMCID: PMC11100877
- DOI: 10.21203/rs.3.rs-4319658/v1
Renalase Levels are Decreased in Maternal Blood and Placental Tissues in Pregnancies Associated with Preterm Preeclampsia
Abstract
Preeclampsia (PEC) is a complication of pregnancy associated with hypertension and the risk of eclampsia. The pathophysiology of PEC is unknown and identifying factors associated with PEC during pregnancy is crucial for placental, fetal, and maternal health. Renalase (RNLS) is an anti-inflammatory secretory flavoprotein associated with hypertension. Recent data demonstrated a correlation between maternal serum RNLS and PEC, and work from our group identified RNLS expression in the placenta. However, it remains unknown whether RNLS levels in placenta are altered by preeclampsia. Additionally, it is unclear if there is a differential effect of preterm and term PEC on RNLS. We demonstrate that serum RNLS was reduced in preterm cases of PEC. Similarly, placental RNLS was diminished in the chorion of preterm cases of PEC. However, a reduction of RNLS in the decidua was observed with all cases of PEC, while the levels of RNLS within the placental villi were similar in all cases. Overall, we demonstrate that RNLS correlates with PEC both systemically in maternal serum and locally within the placenta, with variable effects on the different layers of the placenta and more pronounced in preterm cases.
Keywords: Maternal Serum; PEC; Placenta; Preeclampsia; RNLS; Renalase.
Conflict of interest statement
Competing Interests G.D. is a named inventor on several issued patents related to the discovery and therapeutic use of renalase. Renalase is licensed to Bessor Pharma, and G.D. holds an equity position in Bessor and its subsidiary Personal Therapeutics. All other authors do not have any competing interests to disclose.
Figures
Similar articles
-
Expert review: preeclampsia Type I and Type II.Am J Obstet Gynecol MFM. 2023 Dec;5(12):101203. doi: 10.1016/j.ajogmf.2023.101203. Epub 2023 Oct 21. Am J Obstet Gynecol MFM. 2023. PMID: 37871693 Review.
-
Renalase and its receptor, PMCA4b, are expressed in the placenta throughout the human gestation.Sci Rep. 2022 Mar 23;12(1):4953. doi: 10.1038/s41598-022-08817-6. Sci Rep. 2022. PMID: 35322081 Free PMC article.
-
An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array.Am J Obstet Gynecol. 2022 Feb;226(2S):S963-S972. doi: 10.1016/j.ajog.2020.10.023. Epub 2021 Mar 9. Am J Obstet Gynecol. 2022. PMID: 33712272 Review.
-
Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia.Am J Obstet Gynecol. 2021 Mar;224(3):298.e1-298.e8. doi: 10.1016/j.ajog.2020.08.055. Epub 2020 Aug 25. Am J Obstet Gynecol. 2021. PMID: 32853537 Free PMC article.
-
[The changes of LCHAD in preeclampsia with different clinical features and the correlation with NADPH P47-phox, p38MAPK-α, COX-2 and serum FFA and TG].Zhonghua Fu Chan Ke Za Zhi. 2015 Feb;50(2):92-100. Zhonghua Fu Chan Ke Za Zhi. 2015. PMID: 25877604 Chinese.
References
-
- Odegård RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Preeclampsia and fetal growth. Obstet Gynecol. 2000;96(6):950–955. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources